DE3881249T2 - Fettsaeureamide als acyl-coa-inhibitoren: cholesterolacyltransferase. - Google Patents

Fettsaeureamide als acyl-coa-inhibitoren: cholesterolacyltransferase.

Info

Publication number
DE3881249T2
DE3881249T2 DE8888102644T DE3881249T DE3881249T2 DE 3881249 T2 DE3881249 T2 DE 3881249T2 DE 8888102644 T DE8888102644 T DE 8888102644T DE 3881249 T DE3881249 T DE 3881249T DE 3881249 T2 DE3881249 T2 DE 3881249T2
Authority
DE
Germany
Prior art keywords
trimethoxyphenyl
dimethyl
carbon atoms
methyl
tetradecanamide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8888102644T
Other languages
German (de)
English (en)
Other versions
DE3881249D1 (en
Inventor
Milton Louis Hoefle
Ann Holmes
Bruce David Roth
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Warner Lambert Co LLC
Original Assignee
Warner Lambert Co LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co LLC filed Critical Warner Lambert Co LLC
Publication of DE3881249D1 publication Critical patent/DE3881249D1/de
Application granted granted Critical
Publication of DE3881249T2 publication Critical patent/DE3881249T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/40—Acylated substituent nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/02—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C07C233/04—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C233/07—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/02—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C07C233/09—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to carbon atoms of an acyclic unsaturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
DE8888102644T 1987-02-24 1988-02-23 Fettsaeureamide als acyl-coa-inhibitoren: cholesterolacyltransferase. Expired - Fee Related DE3881249T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/017,960 US4716175A (en) 1987-02-24 1987-02-24 Saturated fatty acid amides as inhibitors of acyl-CoA:cholesterol acyltransferase

Publications (2)

Publication Number Publication Date
DE3881249D1 DE3881249D1 (en) 1993-07-01
DE3881249T2 true DE3881249T2 (de) 1993-09-16

Family

ID=21785503

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8888102644T Expired - Fee Related DE3881249T2 (de) 1987-02-24 1988-02-23 Fettsaeureamide als acyl-coa-inhibitoren: cholesterolacyltransferase.

Country Status (17)

Country Link
US (1) US4716175A (enExample)
EP (1) EP0283742B1 (enExample)
JP (1) JPH07121895B2 (enExample)
KR (1) KR880009933A (enExample)
AT (1) ATE89814T1 (enExample)
CA (1) CA1336913C (enExample)
DE (1) DE3881249T2 (enExample)
DK (1) DK165406C (enExample)
ES (1) ES2056843T3 (enExample)
FI (1) FI89593C (enExample)
HK (1) HK148195A (enExample)
IE (1) IE59998B1 (enExample)
MX (1) MX9203139A (enExample)
NO (1) NO174043C (enExample)
NZ (1) NZ223410A (enExample)
PT (1) PT86811B (enExample)
ZA (1) ZA88604B (enExample)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8827152D0 (en) * 1988-11-21 1988-12-29 Wellcome Found Anti-atherosclerotic diaryl compounds
US5290814A (en) * 1988-11-21 1994-03-01 Burroughs Wellcome Co. Anti-atherosclerotic diaryl compounds
US5153226A (en) * 1989-08-31 1992-10-06 Warner-Lambert Company Acat inhibitors for treating hypocholesterolemia
WO1991004027A1 (en) * 1989-09-15 1991-04-04 Pfizer Inc. New n-aryl and n-heteroarylamide and urea derivatives as inhibitors of acyl coenzyme a: cholesterol acyl transferase (acat)
AU6659090A (en) * 1989-11-16 1991-06-13 Warner-Lambert Company Acat inhibitors
AU7745991A (en) * 1990-04-11 1991-10-30 Warner-Lambert Company Amide ester acat inhibitors
US5149709A (en) * 1990-07-03 1992-09-22 Schering Corporation Inhibitors of acyl-coenzyme A: cholesterol acyl transferase
CA2087423A1 (en) * 1990-07-25 1992-01-26 Tatsuki Shiota Benzopyran derivative, process for producing the same and pharmaceutical composition containing the same
US5668136A (en) * 1990-09-25 1997-09-16 Eisai Co., Ltd. Trisubstituted benzene derivatives, composition and methods of treatment
WO1992009572A1 (en) * 1990-11-26 1992-06-11 Taisho Pharmaceutical Co., Ltd. Anilide derivative
FR2673625B1 (fr) * 1991-03-08 1993-05-07 Adir Nouveaux derives d'acylaminophenol, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
US5420164A (en) * 1991-04-04 1995-05-30 Yoshitomi Pharmaceutical Industries, Ltd. Cycloalkylurea compounds
JP3087307B2 (ja) * 1991-12-25 2000-09-11 大正製薬株式会社 アニリド誘導体
RU94046149A (ru) * 1992-05-28 1996-11-27 Пфайзер Инк. (US) Новые n-арил и n-гетероарил производные мочевины как ингибиторы ацил кофермента а:холестерин ацил трансферазы (асат) фармацевтическая композиция, способ ингибирования (асат)
WO1994002452A1 (fr) * 1992-07-20 1994-02-03 Eisai Co., Ltd. Derive du benzene
US5321031A (en) * 1992-09-23 1994-06-14 Schering Corporation 1,2-disubstituted ethyl amides as inhibitors of ACAT
CA2107196A1 (en) * 1992-09-29 1994-03-30 Mitsubishi Chemical Corporation Carboxamide derivatives
US5565472A (en) * 1992-12-21 1996-10-15 Pfizer Inc. 4-aryl-3-(heteroarylureido)-1,2-dihydro-2-oxo-quinoline derivatives as antihypercholesterolemic and antiatherosclerotic agents
US5534529A (en) * 1993-06-30 1996-07-09 Sankyo Company, Limited Substituted aromatic amides and ureas derivatives having anti-hypercholesteremic activity, their preparation and their therapeutic uses
NZ264063A (en) * 1993-08-13 1995-11-27 Nihon Nohyaku Co Ltd N-(2-phenylpyrid-3-yl)- and n-(4-phenylpyrimidin-5-yl)-n'-phenylurea derivatives and pharmaceutical compositions
US5596001A (en) * 1993-10-25 1997-01-21 Pfizer Inc. 4-aryl-3-(heteroarylureido)quinoline derivatves
IT1265209B1 (it) * 1993-11-22 1996-10-31 Pierrel Spa Difenilimidazoli utili nel trattamento di dislipidemia, arteriosclerosi e malattie coronariche procedimento per la loro
US6133326A (en) 1994-08-31 2000-10-17 Pfizer Inc Compositions and methods for decreasing sebum production
KR960031425A (ko) * 1995-02-08 1996-09-17 시미주 마사미 다중불포화된 지방산 잔기를 갖는 아닐린 유도체 및 그의 용도
HUP0301010A3 (en) * 2000-02-02 2005-03-29 Warner Lambert Co Dual inhibitors of cholesteryl ester and wax ester synthesis for sebaceous gland disorders and pharmaceutical compositions containing them
AU4368001A (en) * 2000-03-16 2001-09-24 Neurogen Corporation 5-substituted arylpyrimidines
US20040072903A1 (en) * 2001-05-08 2004-04-15 Auerbach Bruce Jeffrey Carboxyalkylether-acat inhibitors combinations
EP1281399A3 (en) * 2001-08-01 2004-02-11 Warner-Lambert Company Dual inhibitors of wax ester and cholesteryl ester synthesis for inhibiting sebum production
PT1725234E (pt) 2004-03-05 2013-03-04 Univ Pennsylvania Métodos com efeitos secundários reduzidos para tratamento de patologias ou doenças associadas a hiperlipidemia e hipercolesterolemia
US20100210633A1 (en) * 2006-10-12 2010-08-19 Epix Delaware, Inc. Carboxamide compounds and their use
AU2008335135A1 (en) 2007-12-11 2009-06-18 Cytopathfinder, Inc. Carboxamide compounds and their use as chemokine receptor agonists
EP2341924A4 (en) 2008-10-02 2013-01-23 David Gladstone Inst METHOD FOR THE TREATMENT OF HEPATITIS C VIRUS INFECTIONS
BR112023000808A2 (pt) 2020-07-29 2023-02-07 Amryt Pharmaceuticals Inc Lomitapida para uso em métodos para tratar hiperlipidemia e hipercolesterolemia em pacientes pediátricos

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL238088A (enExample) * 1958-04-14
BE620639A (enExample) * 1961-07-25
SE353319B (enExample) * 1964-08-15 1973-01-29 Sumitomo Chemical Co
DE1618959C3 (de) * 1967-10-04 1978-12-14 Sumitomo Chemical Co., Ltd., Osaka (Japan) Fettsäureamide und Verfahren zu ihrer Herstellung
DE2830351A1 (de) * 1978-07-11 1980-01-24 Consortium Elektrochem Ind Acylanilide
GR69291B (enExample) * 1979-06-25 1982-05-13 May & Baker Ltd
US4410697A (en) * 1980-01-25 1983-10-18 Reanal Finomvegyszergyar Process for the preparation of N-aryl-N'-(mono- or di substituted)-urea derivatives
US4749812A (en) * 1985-05-27 1988-06-07 Mitsui Toatsu Chemicals, Inc. N-(3-chloro-4-isopropylphenyl) carboxamide derivative and selective herbicide
MA20552A1 (fr) * 1985-10-11 1986-07-01 Pan Medica Sa Alkylacarboxamides de pyridylalkylamines,leurs preparations et leurs utilisations

Also Published As

Publication number Publication date
US4716175B1 (enExample) 1993-06-22
DK165406B (da) 1992-11-23
KR880009933A (ko) 1988-10-05
EP0283742A2 (en) 1988-09-28
DE3881249D1 (en) 1993-07-01
PT86811B (pt) 1992-05-29
NO880774D0 (no) 1988-02-23
FI89593C (fi) 1993-10-25
IE880204L (en) 1988-08-24
US4716175A (en) 1987-12-29
MX9203139A (es) 1992-07-01
ES2056843T3 (es) 1994-10-16
ATE89814T1 (de) 1993-06-15
NO174043C (no) 1994-03-09
FI880796A0 (fi) 1988-02-19
ZA88604B (en) 1989-09-27
IE59998B1 (en) 1994-05-18
AU610558B2 (en) 1991-05-23
JPS63253060A (ja) 1988-10-20
NO880774L (no) 1988-08-25
AU1135488A (en) 1988-08-25
EP0283742A3 (en) 1989-07-26
FI880796A7 (fi) 1988-08-25
FI89593B (fi) 1993-07-15
CA1336913C (en) 1995-09-05
PT86811A (pt) 1988-03-01
DK165406C (da) 1993-04-13
HK148195A (en) 1995-09-22
EP0283742B1 (en) 1993-05-26
NO174043B (no) 1993-11-29
NZ223410A (en) 1989-11-28
DK94188D0 (da) 1988-02-23
DK94188A (da) 1988-08-25
JPH07121895B2 (ja) 1995-12-25

Similar Documents

Publication Publication Date Title
DE69012116T2 (de) Antihyperlipidemische und antiartherosklerotische harnstoffverbindungen.
DE3873992T2 (de) Blutfetterniedrigende und antiatherosclerotische harnstoff-verbindungen.
DE68906940T2 (de) Antihyperlipidemische und antiatherosclerotische Verbindungen und Zusammensetzungen.
DE69417885T2 (de) N-acylsulfaminsäureester (oder thioester), n-acylsulfonamide, und n-sulfonylcarbamidsäureester (oder thioester) als hypercholesterolemische mittel
EP0207331B1 (de) Neue feste Formen von 2-Äthoxy-4-[N-(1-(2-piperidino-phenyl)-3-methyl-1-butyl)-aminocarbonylmethyl]-benzoesäure, diese Formen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
DE69133299T2 (de) Aminosulfonylcarbamate
EP0222191B1 (de) 4-Benzyl-1-(2H)-phthalazinon-Derivate
DE1964516C3 (de) 1-Substituierte 3-Propionyl-anilinopyrrolidine, Verfahren zu ihrer Herstellung und Arzneimittel
DE3026201C2 (enExample)
DE68911203T2 (de) N-[[(2,6-disubstituierte)phenyl]N'- arylalkyl] Harnstoffe als antihypercholesterolemische und antiatherosclerotische Mittel.
DE68907359T2 (de) N-(((2,6-disubstituierte)phenyl)-n'-diarylalkyl) harnstoffe als antihyperlipidemische und antiatherosclerotische mittel.
DE2446010A1 (de) 4-(monoalkylamino)benzoesaeurederivate und verfahren zu ihrer herstellung
DE2414680C2 (de) Substituierte 2-Furancarbonsäuren und 2-Furancarbonsäureester, Verfahren zu ihrer Herstellung und Arzneimittel, die diese Verbindungen enthalten
EP0574808A1 (de) Amidin-Biphenylderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
JPH07121895B2 (ja) アシル‐ＣｏＡ：コレステロールアシル転移酵素の阻害剤としての飽和脂肪酸アミド
DE69120287T2 (de) Aminosulfonylharnstoff-acat-inhibitoren
EP0058341A1 (de) Azepinderivate, ihre Herstellung und diese enthaltende Arzneimittel
AT391313B (de) Verfahren zur herstellung von neuen substituierten n-aryl-harnstoffen
EP0016371A1 (de) Neue Harnstoffderivate, Verfahren und Zwischenprodukte zu deren Herstellung und Arzneimittel enthaltend ein solches Harnstoffderivat sowie die Verwendung eines solchen Harnstoffderivates bei der Bekämpfung von Krankheiten
DE69107217T2 (de) Oxysulfonylharnstoff-acat-inhibitoren.
DE3402060A1 (de) Substituierte 5,11-dihydro-6h-dibenz(b,e)azepin-6-one, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE69106386T2 (de) Oxysulfonylcarbamate.
DE2723051A1 (de) N-(acyl)-p-amino-n'-(monosubstit.)- benzamide sowie diese enthaltende arzneimittel
DE2157272B2 (de) Verwendung von bis-(p-Chlorphenoxy)acetylharnstoff
DE69423055T2 (de) Indol Derivate als Glutamat Antagonisten

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee